Anthropic reports early results using Claude in drug development
Anthropic has partnered with six organizations developing medicines and started its own drug discovery programs, using Claude across many development tasks.
By GennnAi··1 min read
ClaudeClaude CodeBigHat BiosciencesBristol Myers SquibbDivergence LabsEnvedaGenerate BiomedicinesThe Column GroupRechercheUsagesFlash
At Generate Biomedicines, a CAR-T design about 70% shorter let immune cells make roughly 10 times as many receptors. For Divergence Labs, Claude generated about 35,000 antibody designs in a month, yielding three IgE binders and 20 that dislodge it. BigHat tested about 1,010 variants in 10 weeks. Anthropic has already prioritized specific model improvements based on these lessons. Anthropic plans to scale up this work substantially.
Source: Anthropic, published on October 27, 2026.